VELOCITY PHARMACEUTICAL HOLDINGS 13G

Company

Altimmune, Inc.

Filed

February 14, 2020

Accession Number

0001068238-20-000055

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →